BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 22459609)

  • 1. [Cisplatin induced reversible posterior leukoencephalopathy].
    Díaz Díaz J; Germán Díaz M; Barrios López M; Martinez De Aragón A; Simón De Las Heras R; Camacho Salas A
    An Pediatr (Barc); 2012 Oct; 77(4):281-2. PubMed ID: 22459609
    [No Abstract]   [Full Text] [Related]  

  • 2. Amifostine protects against cisplatin-induced nephrotoxicity in a child with medulloblastoma.
    Hayek M; Srinivasan A
    Pediatr Hematol Oncol; 2003; 20(3):253-6. PubMed ID: 12637222
    [No Abstract]   [Full Text] [Related]  

  • 3. Reversible posterior leukoencephalopathy syndrome associated with oxaliplatin.
    Pinedo DM; Shah-Khan F; Shah PC
    J Clin Oncol; 2007 Nov; 25(33):5320-1. PubMed ID: 18024878
    [No Abstract]   [Full Text] [Related]  

  • 4. Bortezomib-induced reversible posterior leucoencephalopathy syndrome.
    Kelly K; Kalachand R; Murphy P
    Br J Haematol; 2008 May; 141(5):566. PubMed ID: 18325065
    [No Abstract]   [Full Text] [Related]  

  • 5. Extended use dexamethasone-associated posterior reversible encephalopathy syndrome with cisplatin-based chemotherapy.
    Nguyen MT; Virk IY; Chew L; Villano JL
    J Clin Neurosci; 2009 Dec; 16(12):1688-90. PubMed ID: 19800799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hearing loss in pediatric cancer survivors treated with cisplatin.
    Knight K
    Oncology (Williston Park); 2008 Apr; 22(4 Suppl Nurse Ed):35-7. PubMed ID: 19856560
    [No Abstract]   [Full Text] [Related]  

  • 7. [Posterior reversible encephalopathy syndrome: 5 chemotherapy related cases].
    San Martín García I; Urabayen Alberdi R; Díez Bayona V; Sagaseta de Ilúrdoz Uranga M; Esparza Estaun J; Molina Garicano J; Berisa Prado S
    An Pediatr (Barc); 2014 Feb; 80(2):117-21. PubMed ID: 23786801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible posterior leukoencephalopathy syndrome following R-CHOP therapy for diffuse large B-cell lymphoma.
    Hosoi M; Yamamoto G; Imai Y; Kurokawa M
    Ann Hematol; 2010 Feb; 89(2):207-8. PubMed ID: 19582454
    [No Abstract]   [Full Text] [Related]  

  • 9. [Reversible posterior leukoencephalopathy: the guilty list is increasing].
    Alaña M; Navarro M; Pascual J
    Neurologia; 2008 Mar; 23(2):137; author reply 137-8. PubMed ID: 18322836
    [No Abstract]   [Full Text] [Related]  

  • 10. Reversible posterior leukoencephalopathy syndrome following intravenous paclitaxel and intraperitoneal cisplatin chemotherapy for fallopian tube cancer.
    Onujiogu N; Lengyel E; Yamada SD
    Gynecol Oncol; 2008 Dec; 111(3):537-9. PubMed ID: 18554701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible posterior leukoencephalopathy syndrome during regorafenib treatment: a case report and literature review of reversible posterior leukoencephalopathy syndrome associated with multikinase inhibitors.
    Myint ZW; Sen JM; Watts NL; Druzgal TJ; Nathan BR; Ward MD; Boyer JE; Fracasso PM
    Clin Colorectal Cancer; 2014 Jun; 13(2):127-30. PubMed ID: 24461491
    [No Abstract]   [Full Text] [Related]  

  • 12. L-asparaginase-induced posterior reversible encephalopathy syndrome during acute lymphoblastic leukemia treatment in children.
    Hourani R; Abboud M; Hourani M; Khalifeh H; Muwakkit S
    Neuropediatrics; 2008 Feb; 39(1):46-50. PubMed ID: 18504683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible posterior leukoencephalopathy syndrome induced by vinorelbine.
    Chen YH; Huang CH
    Clin Breast Cancer; 2012 Jun; 12(3):222-5. PubMed ID: 22424944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features of encephalopathy in children with cancer requiring cranial magnetic resonance imaging.
    Lim YJ; Kim HJ; Lee YJ; Seol IJ; Lee YH
    Pediatr Neurol; 2011 Jun; 44(6):433-8. PubMed ID: 21555054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible posterior leukoencephalopathy induced by cancer chemotherapy.
    Baytan B; Ozdemir O; Demirkaya M; Evim MS; Gunes AM
    Pediatr Neurol; 2010 Sep; 43(3):197-201. PubMed ID: 20691942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible posterior leukoencephalopathy syndrome in Chinese children induced by chemotherapy: a review of five cases.
    Belaramani KM; Lai V; Li CH; Lee AC; Kwong NS
    Hong Kong Med J; 2011 Feb; 17(1):61-6. PubMed ID: 21282828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Posterior reversible leukoencephalopathy syndrome caused by cisplatin: a case report].
    Romano LM; de Robles P; Ioli P; García-Saiz E
    Rev Neurol; 2005 Nov 1-15; 41(9):573-4. PubMed ID: 16254865
    [No Abstract]   [Full Text] [Related]  

  • 18. An Unusual Cause of Hemorrhagic Cystitis in a Teenager With Medulloblastoma.
    Slack D; Ray S; Lee B; Sastry J
    J Pediatr Hematol Oncol; 2021 Aug; 43(6):e861-e863. PubMed ID: 32925398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left-right asymmetry in hearing loss following cisplatin therapy in children--the left ear is slightly but significantly more affected.
    Schmidt CM; Knief A; Lagosch AK; Deuster D; am Zehnhoff-Dinnesen A
    Ear Hear; 2008 Dec; 29(6):830-7. PubMed ID: 18772725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posterior reversible encephalopathy syndrome after bevacizumab treatment presenting to the ED as chest pain and headache.
    Miller AH; Monteiro de Oliveira Novaes JA; Brock PA; Sandoval M
    Am J Emerg Med; 2016 Sep; 34(9):1916.e1-2. PubMed ID: 26947375
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.